Measuring Health-related Quality of Life in Clinical Trials (USA)
	Mapi Research Institute , New York, New York 2000/11/16- 2000/11/17
	Integrating Health-related Quality of Life (HRQL) assessment into clinical trials is an increasingly significant focus for the pharmaceutical industry. HRQL assessment is an effective evaluation of patients well-being and physical functioning; one which interests policy makers and health care payers while maintaining the focus on the patient. Join us for a two-day course on the practical issues of developing and implementing an HRQL assessment strategy in clinical trials; the scoring, analysis and interpretation of HRQL data and submitting HRQL results to the FDA.
	Organized by:	Mapi Research Institute
	Invited Speakers:	Speakers: Linda Abetz 1, Isabelle Girod 2, Isabelle Mear 3, John Ware 4, 1. Mapi Values , Manchester, UK; 2. Mapi Values , Lyon, France; 3. Mapi Research Institute , Lyon, France; 4. Tufts University School of Medicine, Boston, Mass
	Deadline for Abstracts:	no abstracts necessary for this course
	Registration:	The registration fee is $1,200.00 for both days, or $700.00 for one day only, and includes tuition, dinner with the speakers the evening of November 15, educational materials, course completion certificate, lunches and refreshment breaks. Please register prior to the September 29 deadline in order to attend the session, as space is limited. Deadline for Application: September 29, 2000
	Email for Requests and Registration:	mbarberan@mapi.fr
	Posted by: Marissa Vicari   Host: lsi67.dtr.fr date: April 04, 2000 11:14:20 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.